Effect of Nutrient Delivery Pattern on Biological Rhythms in Human Skeletal Muscle
NCT ID: NCT03906409
Last Updated: 2023-04-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2019-02-28
2022-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of Energy Intake and Short-term Disuse on Muscle Protein Synthesis Rates and Skeletal Muscle Mass in Middle-aged Adults.
NCT04900701
Fasting and Exercise-induced Changes in Human Skeletal Muscle
NCT03811717
Effects of Early Time Restricted Eating on Muscle Performance in Resistance Trained Individuals
NCT05908201
Effects of Acute Energy Deficit and Aerobic Exercise on Muscle Quality
NCT05203133
Modulation of Muscle Protein Metabolism by Essential Amino Acids
NCT01890369
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It remains unknown whether the interaction of such factors may affect the biological rhythms previously documented in human skeletal muscle. In particular, from a basic science perspective, the fundamental contrast between frequent versus infrequent feeding warrants investigation. To this end, 16-24 healthy adults will be randomly allocated to receive their individual daily energy requirements delivered via naso-gastric infusion either continuously over 24 hours (n=8-12; CONSTANT) or as two bolus infusions at the start (0800 h) and mid-point (2000 h) of the monitoring period (n=8-12; BOLUS). Serial skeletal muscle (vastus lateralis) biopsies will be sampled every 4 hours over a controlled 24-h sleep-wake cycle.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Constant
Participants will be provided with their daily energy requirements in a continuous drip across the day (1 ml/minute).
Constant
Participants will be provided with their daily energy requirements in a continuous drip across the day (1 ml/minute).
Bolus
Participants will be provided with their daily energy requirements in two bolus feeds. One at 08:00-08:15 and one at 20:00-20:15
Bolus
Participants will be provided with their daily energy requirements in two bolus feeds. One at 08:00-08:15 and one at 20:00-20:15
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Constant
Participants will be provided with their daily energy requirements in a continuous drip across the day (1 ml/minute).
Bolus
Participants will be provided with their daily energy requirements in two bolus feeds. One at 08:00-08:15 and one at 20:00-20:15
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be able and willing to give informed oral and written consent, complete and meet the defined criteria of pre-study questionnaires and screens,
* Have a regular sleep cycle with a sleep duration between 6 and 8 hours, do not exhibit extreme morning or evening preference (Horne and Ostberg, 1976)
* Agree to keep a constant sleep/wake cycle with a self-selected 8 hour sleep duration (from which it cannot be deviated by more than 30 minutes) for one week prior to the lab study,
* Obtain 15 minutes of sunlight within 1.5 hours of waking up and agree to nap only within a 4 h designated nap window for one week prior to the lab study,
* Allow confirmation of compliance to these instructions by wearing ActiHeart monitors continuously and complete daily sleep and event diaries for one week before the study session,
* Agree to refrain from alcohol, caffeine, heavy exercise and certain food components TWO days before the study session,
* Agree to weigh and record daily meals (based on individual energy requirements) for TWO days prior to the study,
* Agree to refrain from prescribed and 'over the counter' medication and food/vitamin supplements for a wash-out period three weeks before and during the study.
Exclusion Criteria
* Any of the inflammatory markers (e.g. aspirin, ibuprofen, antiobiotics, hay fever medication, medication for sore throats and colds)
* And/or any of the endothelial markers (e.g. ACE inhibitors and angiotensin (receptor) blockers, diuretics, Beta-blockers, anti-thrombosis medication),
* Have a history of any circadian or sleep disorder or metabolic, cardiovascular or chronic infectious / inflammatory disease as confirmed by the GP or the pre-study questionnaires (e.g. a Pittsburgh Sleep Quality Index \> 5 will result in exclusion),
* Have a history of psychiatric or neurological disease or drug and alcohol abuse,
* Have donated over 400 ml of blood in the three months preceding the study,
* Have participated in shift work or have travelled across more than two time zones within three weeks of the study,
* Do not keep a regular sleep-wake cycle,
* Do not refrain from alcohol, caffeine containing drinks (e.g. coffee, coke, tea, redbull), heavy exercise and certain foods (e.g. those high in fat and green vegetables) TWO days before and during the laboratory session,
* Normally consume more than 4 cups of caffeinated beverages (e.g. tea, coffee, cola) daily
* Smokers
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société des Produits Nestlé (SPN)
INDUSTRY
University of Bath
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
James Betts
Professor James Betts
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Harry A Smith, MSci
Role: PRINCIPAL_INVESTIGATOR
University of Bath
James A Betts, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Bath
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Bath
Bath, Somerset, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Christou S, Wehrens SMT, Isherwood C, Moller-Levet CS, Wu H, Revell VL, Bucca G, Skene DJ, Laing EE, Archer SN, Johnston JD. Circadian regulation in human white adipose tissue revealed by transcriptome and metabolic network analysis. Sci Rep. 2019 Feb 25;9(1):2641. doi: 10.1038/s41598-019-39668-3.
Perrin L, Loizides-Mangold U, Chanon S, Gobet C, Hulo N, Isenegger L, Weger BD, Migliavacca E, Charpagne A, Betts JA, Walhin JP, Templeman I, Stokes K, Thompson D, Tsintzas K, Robert M, Howald C, Riezman H, Feige JN, Karagounis LG, Johnston JD, Dermitzakis ET, Gachon F, Lefai E, Dibner C. Transcriptomic analyses reveal rhythmic and CLOCK-driven pathways in human skeletal muscle. Elife. 2018 Apr 16;7:e34114. doi: 10.7554/eLife.34114.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.